RankAlpha logo
Back to Rankings

VRCA

VerricaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
VRCA vs peer average
46/100
VRCA vs. peer average (D vs. D)
Grade spread
B 2 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KLRS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $95.61M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKLRSKalaris Therapeutics
VRCA
Verrica
KLRS
Kalaris Therapeutics
Grade
D
B
Momentum
46
74
Value
41
59
Sentiment
-
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs KLRS

VRCA / KLRS
Grade Position
In line
VRCA vs. peer average (D vs. D)
46/100
Momentum
46
KLRS
Value
41
KLRS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VRCA
1
KLRS
Kalaris Therapeutics Inc Common
B
80/100
-2
2
RANI
Rani Therapeutics Holdings Inc Class A Common
B
80/100
-2
3
ENTX
Entera Bio Ltd Common
D
40/100
Even
4
BMEA
Biomea Fusion Inc Common
D
40/100
Even
5
INO
Inovio Pharmaceuticals Inc Common
D
40/100
Even
KLRS is the first peer returned for this comparison set.